Skip to main content


Page 1 of 7

  1. Designing and preparing a co-delivery system based on polymeric micelles have attracted in recent years. Co-delivery of anti-cancer agents within pH-sensitive polymeric micelles could provide superior advantag...

    Authors: Leila Farhoudi, Seyedeh Maryam Hosseinikhah, Amin Kazemi-Beydokhti, Leila Arabi, Seyedeh Hoda Alavizadeh, Seyedeh Alia Moosavian and Mahmoud Reza Jaafari
    Citation: Cancer Nanotechnology 2024 15:37
  2. Resveratrol (RVS) is a stilbene derivative polyphenolic compound extensively recognized for its anti-inflammatory, antioxidant and anti-aging properties, along with its enormous promise in carcinoma treatment....

    Authors: Mai O. Kadry
    Citation: Cancer Nanotechnology 2024 15:36
  3. Anlotinib is a targeted therapy indicated for some malignancies, including advanced non-small cell lung cancer (NSCLC). However, noninvasive biomarkers for identifying patients who will benefit from this disea...

    Authors: Aimi Huang, Fuchuang Zhang, Jiyang Zhang, Xiaoya Xu, Zhikuan Li, Sheng Chen, Baoning Nian, Dadong Zhang, Baohui Han, Aiqin Gu and Weimin Wang
    Citation: Cancer Nanotechnology 2024 15:35
  4. 3D printing technology is a powerful tool in scaffold engineering for biomedical applications, especially in anticancer activities and drug delivery. The present study developed a 3D-printed gelatin–alginate s...

    Authors: Neda Mahdizadeh, Mahtab Khorshid Shabestari, Farzaneh Tafvizi and Parvin Khodarahmi
    Citation: Cancer Nanotechnology 2024 15:33
  5. Extracellular vesicles (EVs) harbor several signaling molecules to maintain intercellular communication. Based on the exosomal cargo type, metabolic, genomic, and proteomic status of parent cells can be invest...

    Authors: Ehsan Dezhakam, Balal Khalilzadeh, Abdolhossein Naseri, Reza Rahbarghazi, Elham Mahmoudi, Aligholi Niaei, Mahdi Mahdipour, Narges Mardi and Ibrahim Isildak
    Citation: Cancer Nanotechnology 2024 15:30
  6. The therapeutic resistance to ionizing radiation (IR) and angiogenesis inhibitors is a great challenge for clinicians in the treatment of glioblastoma, which is associated with Hepatocyte growth factor (HGF)/M...

    Authors: Jian zhang, Tao Li, Ling Liu, Zhenpu Chen, Li Li, Xiaoxuan Yao, Jiaxing Cheng, Xiaoyuan Hu, Jiyin Guo, Ruilei Li, Chunlei Ge, Eng-Ang Ling and Hong Yao
    Citation: Cancer Nanotechnology 2024 15:29
  7. Recent advances in clinical transformation research have focused on chemodynamic theranostics as an emerging strategy for tackling cancer. Nevertheless, its effectiveness is hampered by the tumor's glutathione...

    Authors: Mohamed M. Swidan, Nehal S. Wahba and Tamer M. Sakr
    Citation: Cancer Nanotechnology 2024 15:28
  8. The tumor-specific immune responses, essential for removing residual lesions and preventing tumor metastases, can be stimulated by tumor-associated antigens (TAAs) released following photothermal therapy (PTT)...

    Authors: Liu Xu, Ruoyu Wu, Jiajing Ni, Lufei Jin, Kaiwei Xu, Yuchao Zhu, Lu Hong, Chunqu Chen, Linwei Wang, Lubin Zhu, Weijian Zhou, Wenqi Shen and Jianhua Wang
    Citation: Cancer Nanotechnology 2024 15:27
  9. The objective of this study was to synthesize a novel antibacterial and anticancer nanoformulation using aloe vera-derived carbon quantum dots (Cdot) and chromium-doped alumina nanoparticles (Al2O3:Cr/Cdot NPs) v...

    Authors: Merat Karimi, Mina Homayoonfal, Mostafa Zahedifar, Amirreza Ostadian, Reyhaneh Adibi, Bahareh Mohammadzadeh, Arash Raisi, Fatemeh Ravaei, Somaye Rashki, Mahsa Khakbraghi, Michael Hamblin, Zahra Kheirkhah, Ehsan Sadeghi, Majid Nejati and Hamed Mirzaei
    Citation: Cancer Nanotechnology 2024 15:26
  10. The utilization of liposomes in drug delivery has garnered significant attention due to their efficient drug loading capacity and excellent biocompatibility, rendering them a promising platform for tumor thera...

    Authors: Danhuan Zhang, Lingyun Chen, Yang Zhao, Hao Ni, Qiuying Quan, Jun Ma and Lingchuan Guo
    Citation: Cancer Nanotechnology 2024 15:25
  11. Nanocarrier delivery of small interfering RNAs (siRNAs) to silence cancer-associated genes is a promising method for cancer treatment. Here, we explored the role and mechanisms of PLAG NPs-delivered si-Notch1 ...

    Authors: Dan-dan Li, Jia-cheng Jin, Xuan-wen Liu, Shu-yang Liu, Fu-jian Ji and Tong Liu
    Citation: Cancer Nanotechnology 2024 15:23
  12. Colorectal cancer (CRC) ranks as the third most common cancer globally and the second leading cause of cancer-related mortality. Traditional chemotherapy, while effective, often results in significant side eff...

    Authors: Fateme Momen Eslamiehei, Mansour Mashreghi and Maryam M. Matin
    Citation: Cancer Nanotechnology 2024 15:22
  13. The addition of the cyclin dependent kinase inhibitor (CDKi) dinaciclib to Poly-(ADP-ribose) polymerase inhibitor (PARPi) therapy is a strategy to overcome resistance to PARPi in tumors that exhibit homologous...

    Authors: Paige Baldwin, Shicheng Yang, Adrienne Orriols, Sherrie Wang, Needa Brown and Srinivas Sridhar
    Citation: Cancer Nanotechnology 2024 15:20
  14. The delivery of therapeutic nucleic acids, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASO) into cells, is widely used in gene therapy. Gold nanoparticles (AuNPs) have proved to be ef...

    Authors: Daniela Ferreira, Alexandra R. Fernandes and Pedro V. Baptista
    Citation: Cancer Nanotechnology 2024 15:19
  15. There is a continuous growth of interest in the development of nano-drug delivery systems that could combine therapy and diagnosis of cancer.

    Authors: Anand Kumar Veeramachineni, Thenapakiam Sathasivam, Ragul Paramasivam, Saravanan Muniyandy, Shafii Bin Khamis, Yau Yan Lim and Janarthanan Pushpamalar
    Citation: Cancer Nanotechnology 2024 15:18

    The Correction to this article has been published in Cancer Nanotechnology 2024 15:31

  16. It is crucial to enhance new compounds for the treatment of most malignancies, and graphene oxide/silver nanocomposite (GO/Ag NC) has been paying attention to biomedical applications such as malignancies. In t...

    Authors: Amna H. Faid, M. Abdel Rafea, Sara Gad, Marwa Sharaky and Marwa A. Ramadan
    Citation: Cancer Nanotechnology 2024 15:17
  17. Colorectal cancer (CRC) is a type of cancer that affects the colon or rectum and occurs in individuals over the age of 50, although it can affect people of all ages. Quercetin is a flavonoid, which is a type o...

    Authors: Jamal Moideen Muthu Mohamed, Fazil Ahmad, Mohamed El-Sherbiny, Mohammed Ahmad Al Mohaini, Krishnaraju Venkatesan, Yahya Bin Abdullah Alrashdi, Mamdouh Basheir Eldesoqui, Adel Ehab Ibrahim, Amal Fahmy Dawood, Ateya Megahed Ibrahim and Sami El Deeb
    Citation: Cancer Nanotechnology 2024 15:16
  18. Hepatocellular carcinoma (HCC) is a common malignant tumor with high mortality and recurrence rate. The efficacy of the first-line drug sorafenib is impeded by drug resistance, which is closely related to acti...

    Authors: Shengjie Ye, Xier Pan, Linghui Zou, Shuting Ni, Lei Zhang, Yanlong Hong and Kaili Hu
    Citation: Cancer Nanotechnology 2024 15:15

    The Correction to this article has been published in Cancer Nanotechnology 2024 15:32

  19. The medical field is faced with the difficult task of developing a new approach to curing cancer, which is prevalent in organs such as the breast and ovaries and has a high mortality rate. Since chemotherapy i...

    Authors: Mona Safari Sharafshadeh, Farzaneh Tafvizi, Parvin Khodarahmi and Somayeh Ehtesham
    Citation: Cancer Nanotechnology 2024 15:14
  20. Nowadays, silver nanoparticles (AgNPs) have attracted the attention of many researchers due to their special physical, chemical, and biological properties. There is strong evidence that biogenic AgNPs can act ...

    Authors: Haiwei Xiong, Xiaoyan Nie, Wei Cao, Jia Zhu, Jian Chen, Ruihao Liu and Yingliang Li
    Citation: Cancer Nanotechnology 2024 15:13
  21. The morbidity and mortality of gastrointestinal tumours remain high worldwide. Surgical resection is currently the most critical radical therapeutic schedule, while postoperative complications and sentinel lym...

    Authors: Liting Sun, Cong Meng, Zhongtao Zhang, Yao Luo, Zhengyang Yang and Hongwei Yao
    Citation: Cancer Nanotechnology 2024 15:12
  22. The research aims to observe the difference in the effect of preoperative doxorubicin curcumin co-loaded lipid nanoparticles (DOX+CUR LPNs) and doxorubicin (VAD) in the treatment of osteosarcoma.

    Authors: Xinyan Lu, Peng Zhang, Jun Li, Yi Zhou, Bangjun Wang and Zhaoli Lu
    Citation: Cancer Nanotechnology 2024 15:11
  23. Multidrug resistance (MDR) is one of the main reasons affecting the efficacy of chemotherapy in breast cancer (BC). Our previous studies constructed polymer lipid hybrid nanoparticles encapsulated with Emodin ...

    Authors: Honghui Gu, Fansu Meng, Haidong Sun, Lina Yang, Qi Li, Zhong Chen, Tiange Cai, Zhenjiang Yang and Yu Cai
    Citation: Cancer Nanotechnology 2024 15:10
  24. Metallofullerenes are an important type of metallic nanomaterial with promising applications in several medical fields. Thermal ablation, including radiofrequency ablation (RFA) and microwave ablation (MWA), i...

    Authors: Jie Sun, Zhengyao Chang, Xudong Gao, Huiwei Sun, Yantao Chai, Xiaojuan Li, Xiaoming Zhang and Fan Feng
    Citation: Cancer Nanotechnology 2024 15:8
  25. The present study proposed to design nanostructured lipid carriers (NLC) coated with chitosan (CS) conjugated folate (FA) for the targeted delivery of Osthole (OST) to the HT-29 colon cancer cell line and impr...

    Authors: Ghazal Hosseini Torshizi, Masoud Homayouni Tabrizi, Ehsan Karimi, Atefeh Younesi and Zahra Larian
    Citation: Cancer Nanotechnology 2024 15:7
  26. Glioblastoma multiforme (GBM) is nowadays the most aggressive tumor affecting brain in adults with a very poor prognosis due to the limited therapies and the systemic cytotoxicity. Among the different new drug...

    Authors: Valentina Coccè, Eleonora Martegani, Luisa Doneda, Isabella Rimoldi, Giorgio Facchetti, Coffetti Giulia, Giorgio Lucchini, Leda Roncoroni, Aldo Giannì, Costantino Corradini, Giulio Alessandri, Emilio Ciusani, Francesco Cilurzo, Silvia Franzè, Francesca Paino and Augusto Pessina
    Citation: Cancer Nanotechnology 2024 15:5
  27. Ovarian cancer treatment is challenged by resistance and off-target effects. Melittin shows promise against cancer but is limited by its instability and harmful cellular interactions. Our study introduces SiO2...

    Authors: Lihui Si, Shuli Yang, Ruixin Lin, Shiyu Gu, Chuhan Yan and Jia Yan
    Citation: Cancer Nanotechnology 2024 15:4
  28. PD-1/PD-L1 blockade plays a crucial role in cancer immunotherapy. Exploration of new technologies to further enhance the efficacy of PD-1/PD-L1 blockade is therefore of potential medical importance. Nanotherap...

    Authors: Qiping Jiang, Fengjiao Yao, Yacong An, Xialian Lai, Xundou Li, Zhen Yu and Xian-Da Yang
    Citation: Cancer Nanotechnology 2024 15:3
  29. Mesothelin (MSLN) has been implicated in cancer migration, invasion, and prognosis, making it a potential tumor marker. However, the precise role of MSLN in the migration and invasion of malignant pleural meso...

    Authors: Yilong Huang, Shasha Shen, Jie Xiao, Cici Luo, Jiyao Ma, Xin Huang, Tianfu Qi, Chao Gao, Guiyun Li, Fan Li, Bo He, Bingdi Chen and Dan Han
    Citation: Cancer Nanotechnology 2024 15:1
  30. Although liposomes have improved patient safety and the pharmacokinetic profile of free drugs, their therapeutic efficacy has only shown marginal improvement. The incorporation of active-targeted ligands to en...

    Authors: Rezvan Yazdian-Robati, Ehsan Amiri, Hossein Kamali, Aysun Khosravi, Seyed Mohammad Taghdisi, Mahmoud Reza Jaafari, Mohammad Mashreghi and Seyedeh Alia Moosavian
    Citation: Cancer Nanotechnology 2023 14:84
  31. Immune checkpoint blockade (ICB) has achieved unprecedented success in inhibiting the progression and metastasis of many cancers. However, ICB regents as a single treatment have a relatively low overall respon...

    Authors: Yeteng Mu, Yuxin Fan, Lianping He, Nannan Hu, Han Xue, Xingang Guan and Zhijian Zheng
    Citation: Cancer Nanotechnology 2023 14:83
  32. Tumor microparticles (T-MPs) are vesicles released from tumor cells when they receive apoptotic or stimuli signals. T-MPs, which contain some proteins, lipids and nucleic acids from tumor cells, contribute to ...

    Authors: Weiwei Sun, Pingwei Xu, Pengtao Pan, Sheng Guo, Rui Liu, Guojie Ji, Huanhuan Hu, Weidong Li and Lili Dai
    Citation: Cancer Nanotechnology 2023 14:82
  33. Artesunate (ART) has great value in the field of tumor therapy. Interestingly, in this study, we found that ART could obviously induce ferroptosis in hepatocellular carcinoma (HCC) cells, but its low water sol...

    Authors: Dengyun Nie, Ting Guo, Xinyu Zong, Wenya Li, Yinxing Zhu, Miao Yue, Min Sha and Mei Lin
    Citation: Cancer Nanotechnology 2023 14:81
  34. Much in vitro research on the applicability of gold nanoparticles (GNPs) in cancer treatment has been focused on two-dimensional (2D) monolayer models. To improve this, we explored the effect of the combinatio...

    Authors: Kyle Bromma, Wayne Beckham and Devika B. Chithrani
    Citation: Cancer Nanotechnology 2023 14:80
  35. In the present era, we are facing different health problems mainly concerning with drug resistance in microorganisms as well as in cancer cells. In addition, we are also facing the problems of controlling oxid...

    Authors: Pramod C. Mane, Deepali D. Kadam, Ashok N. Khadse, Aditya R. Chaudhari, Supriya P. Ughade, Sachin B. Agawane and Ravindra D. Chaudhari
    Citation: Cancer Nanotechnology 2023 14:79

    The Publisher Correction to this article has been published in Cancer Nanotechnology 2023 14:85

  36. PEGylated nanoparticles (PEG-NPs) are not effective for hematologic malignancies as they lack the enhanced permeability and retention effect (EPR effect). Tumor-targeted PEG-NPs can systemically track lymphoma...

    Authors: Huei-Jen Chen, Yi-An Cheng, Yu-Tung Chen, Chia-Ching Li, Bo-Cheng Huang, Shih-Ting Hong, I.-Ju Chen, Kai-Wen Ho, Chiao-Yun Chen, Fang-Ming Chen, Jaw-Yuan Wang, Steve R. Roffler, Tian-Lu Cheng and Dung-Ho Wu
    Citation: Cancer Nanotechnology 2023 14:78
  37. Bee pollen extract (BPE)-based polymer nanoparticles (BPENP) were fabricated using bovine serum albumin (BSA) and targeted with folic acid and were further characterized. Mice groups are: Group 1 received sali...

    Authors: Elsayed I. Salim, Magdy E. Mahfouz, Eman A. Eltonouby, Nemany A. N. Hanafy and Ezar H. Hafez
    Citation: Cancer Nanotechnology 2023 14:77
  38. Engineering nanotherapeutics have been extensively studied for cancer therapy. However, the therapeutic efficacy is still severely restricted by biophysiological barriers and intracellular accumulation. Althou...

    Authors: Xinyue Xing, Yuying Zeng, Wanqing Zhong, Wendai Cheng, Chengxin Zhou, Xiaoxu Lu and Liyun Zhong
    Citation: Cancer Nanotechnology 2023 14:76
  39. Radiotherapy (RT) is an essential component in the treatment regimens for many cancer patients. However, the dose escalation required to improve curative results is hindered due to the normal tissue toxicity t...

    Authors: Nolan Jackson, Iona Hill, Abdulaziz Alhussan, Kyle Bromma, Jessica Morgan, Belal Abousaida, Yasmin Zahra, Yuri Mackeyev, Wayne Beckham, Steven Herchko, Sunil Krishnan and Devika Basnagge Chithrani
    Citation: Cancer Nanotechnology 2023 14:75
  40. Breast cancer is the neoplastic disease with the highest incidence and mortality in the female population worldwide. Treatment remains challenging due to various factors. Therefore, it is of great importance t...

    Authors: Camila Sales Nascimento, Naiara Clemente Tavares, Izabella Cristina Andrade Batista, Mônica Maria Magalhães Caetano, Eneida Santos de Oliveira, Stella Garcia Colombarolli, Anna Carolina Pinheiro Lage, Rodrigo Corrêa-Oliveira, Érica Alessandra Rocha Alves, Celso Pinto de Melo and Carlos Eduardo Calzavara-Silva
    Citation: Cancer Nanotechnology 2023 14:74
  41. Prostate cancer (PCa) is one of the fatal illnesses among males globally. PCa-treatment does not include radiotherapy. Chemotherapy eventually causes drug resistance, disease recurrence, metastatic advancement...

    Authors: Ashique Al Hoque, Debasmita Dutta, Brahamacharry Paul, Leena Kumari, Iman Ehsan, Moumita Dhara, Biswajit Mukherjee, Mohiuddin Quadir, Benny Abraham Kaipparettu, Soumik Laha and Shantanu Ganguly
    Citation: Cancer Nanotechnology 2023 14:73

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 4.5
    5-year Journal Impact Factor: 5.1
    Source Normalized Impact per Paper (SNIP): 0.723
    SCImago Journal Rank (SJR): 0.671

    Speed 2023
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 93

    Usage 2023
    Downloads: 328,851
    Altmetric mentions: 109